<DOC>
	<DOCNO>NCT01089348</DOCNO>
	<brief_summary>This phase II multicenter randomize open-label clinical study determine whether treatment Lactofiltrum ( orally administer tablet ) combination antibiotic therapy ( metronidazole ) effective woman bacterial vaginosis . Lactofiltrum composite drug include enterosorbent lignin prebiotic Lactulose . It 's suppose supplement Lactofiltrum standard therapy bacterial vaginosis ( metronidazole administer orally ) improve woman 's general state , lead good recovery clinical , microbiological , biochemical histological feature disease .</brief_summary>
	<brief_title>A Pilot Open-label Randomized Study Lactofiltrum Women With Bacterial Vaginosis</brief_title>
	<detailed_description />
	<mesh_term>Vaginal Diseases</mesh_term>
	<mesh_term>Vaginosis , Bacterial</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>bacterial vaginosis . pregnancy breastfeeding ; concomitant infection disease ; systemic topical treatment antibiotic , steroid , immunosuppressive , cytostatic antimetabolite agent time inclusion ; application intravaginal medicine participation study ; severe disease ; renal hepatic failure ; application pre , probiotic antibiotic 2 week inclusion participation study ; participation clinical study 1 month inclusion participation propose study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Vaginosis , Bacterial</keyword>
	<keyword>Prebiotics</keyword>
	<keyword>Lactofiltrum</keyword>
	<keyword>Therapy</keyword>
</DOC>